Drug development in Alzheimer's disease: the contribution of PET and SPECT

• Asıl Yazarlar: Lieven Denis Herwig Declercq (Yazar), Rik eVandenberghe (Yazar), Koen eVan Laere (Yazar), Alfons eVerbruggen (Yazar), Guy eBormans (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2016-03-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Clinical trials aiming to develop disease-altering drugs for Alzheimer's disease (AD), a neurodegenerative disorder with devastating consequences, are failing at an alarming rate. Poorly defined inclusion- and outcome criteria, due to a limited amount of objective biomarkers, is one of the majo...